Marina Pajic
14PUBLICATIONS
131CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jul 07, 2025
Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma.Patrick Bergsma, Sean Porazinski, Aji Istadi
|Mar 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.Cecilia R Chambers, Supitchaya Watakul, Peter Schofield
|Jul 03, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.Brooke A Pereira, Shona Ritchie, Cecilia R Chambers
|Aug 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.Jessica L Chitty, Michelle Yam, Lara Perryman
|Mar 13, 2023
A CRISPR Path to Finding Vulnerabilities and Solving Drug Resistance: Targeting the Diverse Cancer Landscape and Its Ecosystem.Benjamin McLean, Aji Istadi, Teleri Clack
Pageof 3
Frequent Collaborators
5 joint publications
Paul Timpson
4 joint publications
Daniel A Reed
4 joint publications
David Herrmann
4 joint publications
Jennifer P Morton
4 joint publications
David R Croucher
4 joint publications
Anthony J Gill
4 joint publications
Thomas R Cox
4 joint publications
Max Nobis
3 joint publications
Victoria Lee
3 joint publications
Brooke A Pereira
